Matches in DBpedia 2016-04 for { ?s ?p "OrbusNeich is a global company that designs, develops, manufactures and markets medical devices for the treatment of vascular diseases.In 2013, OrbusNeich received CE mark for the world’s first and only dual therapy stent, the COMBO Dual Therapy Stent. The COMBO Stent features active endothelial progenitor cell (EPC) capture technology, which promotes the accelerated natural healing of the vessel wall after the implantation of a stent."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- OrbusNeich abstract "OrbusNeich is a global company that designs, develops, manufactures and markets medical devices for the treatment of vascular diseases.In 2013, OrbusNeich received CE mark for the world’s first and only dual therapy stent, the COMBO Dual Therapy Stent. The COMBO Stent features active endothelial progenitor cell (EPC) capture technology, which promotes the accelerated natural healing of the vessel wall after the implantation of a stent.".
- Q7100132 abstract "OrbusNeich is a global company that designs, develops, manufactures and markets medical devices for the treatment of vascular diseases.In 2013, OrbusNeich received CE mark for the world’s first and only dual therapy stent, the COMBO Dual Therapy Stent. The COMBO Stent features active endothelial progenitor cell (EPC) capture technology, which promotes the accelerated natural healing of the vessel wall after the implantation of a stent.".
- OrbusNeich comment "OrbusNeich is a global company that designs, develops, manufactures and markets medical devices for the treatment of vascular diseases.In 2013, OrbusNeich received CE mark for the world’s first and only dual therapy stent, the COMBO Dual Therapy Stent. The COMBO Stent features active endothelial progenitor cell (EPC) capture technology, which promotes the accelerated natural healing of the vessel wall after the implantation of a stent.".
- Q7100132 comment "OrbusNeich is a global company that designs, develops, manufactures and markets medical devices for the treatment of vascular diseases.In 2013, OrbusNeich received CE mark for the world’s first and only dual therapy stent, the COMBO Dual Therapy Stent. The COMBO Stent features active endothelial progenitor cell (EPC) capture technology, which promotes the accelerated natural healing of the vessel wall after the implantation of a stent.".